Skip to main content
. 2019 Oct 8;99(2):213–221. doi: 10.1111/aogs.13735

Table 3.

Patient characteristics, ovarian function and fertility outcomes after cryopreserved ovarian tissue autotransplantation

Patient 1a Patient 2 Patient 3 Patient 4a Patient 5 Patient 6 Patient 7b
Disease Breast cancer Breast cancer Hodgkin lymphoma Non‐Hodgkin lymphoma Hodgkin lymphoma Ewing’s sarcoma Breast cancer
Age at OTC (y) 26 32 29 32 22 20 28
Age at transplantation (y)

31

33

35 39

39

40

26 26 38
Transplantation sites

Ovary

Ovary

Ovary and peritoneal Ovary

Ovary

Ovary

Ovary Ovary Ovary
Transplanted ovarian slices (n)

11

11

4 7

8

8

12 6 5
Time to restoration of menstrual cycle (mo)

3.7

6.0 Not restored

3.4

3.0

2.1 2.4 3.0
Duration of ovarian function (mo) Ovarian resection (BRCA1) (38.5) Ongoing (45.0) Ongoing (47.8) Ongoing (57.3) Ongoing (3.3) Ongoing (15)
Pregnancy (n) 1 2 2 1
Fertility techniques None

IVF

None

IVF

None

None
Time to first pregnancy (mo) 24 8 23 6
Pregnancy outcomes 1 live birth (followed by ovarian resection due to BRCA1) 2 live births 1 missed abortion, 2 live births 1 live birth

Abbreviation: IVF, in vitro fertilization; OTC, ovarian tissue cryopreservation.

a

These women underwent 2 autotransplantation procedures.

b

Patient recruitment and ovarian cryopreservation were performed in another hospital.